CVD Equipment sells Tantaline subsidiary; expects ~$250K loss in Q2 2023

CVD EQUIPMENT CORP

Tantaline sold for nominal upfront plus 10% of net profit royalty over 5 years.
Expected loss on sale of approximately $250,000 recorded in Q2 2023.
Tantaline 2022 revenue $1.7M, net income $0.4M; Q1 2023 revenue $0.4M, net income $0.1M.
Divestiture of non-core product line to focus on high-power electronics, EV battery materials, aerospace & defense.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.